BridgeMD
New treatment option for Alzheimer Disease
Official title Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
ClinicalTrials.gov ID: NCT05295615
What this study is testing
- What it's testing
- An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 100
You may be able to join if
- Age ≥ 50 years
- Patients diagnosed with mild to moderate Alzheimer's Dementia defi
- At least an eighth grade of educational achievement
- If female, post-menopausal.
- MMSE score between 16 and 26
You likely can't join if
- The patient lacks capacity to consent to study participation and no surrogate is available to provide consent
- History of epileptic seizures or epilepsy
- Currently taking medication that lowers the seizure threshold
- Presence of depression, bipolar disorder, a psychotic disorder, or any other neurological or psychiatric condition (whether now or in the past)...
- Severe agitation that would interfere with study procedures
- Alcoholism or substance use disorder as defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) within last 5 years...
See the full eligibility criteria
- Age ≥ 50 years
- Patients diagnosed with mild to moderate Alzheimer's Dementia defi
- At least an eighth grade of educational achievement
- If female, post-menopausal.
- MMSE score between 16 and 26
- Capable of providing consent or having a surrogate (e.g., spouse, family member) capable of providing consent if participant lacks consent capacity
- Able and willing to comply with the protocol
- If the participant is receiving a cholinesterase inhibitor and/or memantine, such medication has been prescribed for at least 3 months prior to screening and the dose is stable for at least 60 days prior to screening...
- Spouse, family member or professional caregiver agree and are capable of taking care of the participation of the patient in the study (answering questions regarding the patient's condition, assuming responsibility for...
- Physical clearance for study participation as evaluated by the clinician
- The patient lacks capacity to consent to study participation and no surrogate is available to provide consent
- History of epileptic seizures or epilepsy
- Currently taking medication that lowers the seizure threshold
- Presence of depression, bipolar disorder, a psychotic disorder, or any other neurological or psychiatric condition (whether now or in the past), which the Investigator finds as interfering with the study
- Severe agitation that would interfere with study procedures
- Alcoholism or substance use disorder as defined by Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) within last 5 years (addicted more than one year and or in remission less than 3 years) or...
- Major surgery (defined as any major abdominal, vascular or thoracic surgery requiring general anesthesia and resulting in a period of \>1 week hospitalization) within 4 weeks
- Head anatomy that interferes with the fit of the treatment device
- Participation in another clinical trial within the previous 30 days
- Metal implants in the head, (i.e., cochlear implants, implanted brain stimulators and neurostimulators, aneurysm clips) with the exception of metal implants in mouth
The study team makes the final eligibility decision.
Where it's taking place
- Hackensack, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hackensack, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.